Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
6(67%)
Results Posted
50%(1 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_2
3
33%
Ph not_applicable
2
22%
Ph phase_1
2
22%

Phase Distribution

2

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
2(28.6%)
Phase 2Efficacy & side effects
3(42.9%)
N/ANon-phased studies
2(28.6%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

6

trials recruiting

Total Trials

9

all time

Status Distribution
Active(6)
Completed(2)
Terminated(1)

Detailed Status

Recruiting3
Active, not recruiting3
Completed2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
6
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (28.6%)
Phase 23 (42.9%)
N/A2 (28.6%)

Trials by Status

recruiting333%
active_not_recruiting333%
completed222%
terminated111%

Recent Activity

6 active trials
Showing 5 of 9
recruitingphase_2

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

NCT03418038
recruitingphase_1

Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors

NCT05053971
active_not_recruitingnot_applicable

Cryoablation for the Treatment of Metastatic Cancer

NCT04150939
recruitingphase_1

Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

NCT05688215
active_not_recruitingphase_2

A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma

NCT03880019
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT03418038Phase 2

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Recruiting
NCT05053971Phase 1

Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors

Recruiting
NCT04150939Not Applicable

Cryoablation for the Treatment of Metastatic Cancer

Active Not Recruiting
NCT05688215Phase 1

Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Recruiting
NCT03880019Phase 2

A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma

Active Not Recruiting
NCT04009044Phase 2

Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast

Active Not Recruiting
NCT04759053Not Applicable

Effectiveness of Core-Needle US Guided Biopsy as Primary Tool For Diagnosis of Thyroid Nodules

Completed
NCT00537173

Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer

Terminated
NCT01855503

Breast Cancer Molecular Analysis Protocol

Completed

All 9 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
9